Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $166 | $2 | $32 | $813 |
| Short-Term Investments | $0 | $4 | $0 | $0 |
| Receivables | $52 | $0 | $0 | $42 |
| Inventory | $67 | $10 | $10 | $10 |
| Other Curr. Assets | $74 | $40 | $91 | $23 |
| Total Curr. Assets | $359 | $89 | $157 | $887 |
| Property Plant & Equip (Net) | $2,226 | $2,061 | $1,924 | $1,665 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $14 | $14 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $0 | $0 | $14 |
| Total NC Assets | $2,240 | $2,075 | $1,938 | $1,679 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,598 | $2,164 | $2,095 | $2,567 |
| Liabilities | – | – | – | – |
| Payables | $909 | $218 | $591 | $585 |
| Short-Term Debt | $0 | $0 | $0 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,185 | $456 | $67 | $72 |
| Total Curr. Liab. | $2,094 | $674 | $591 | $621 |
| LT Debt | $40 | $40 | $26 | $26 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14 | $14 | $14 | $14 |
| Total NC Liab. | $54 | $54 | $40 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $17 |
| Total Liabilities | $2,148 | $728 | $631 | $661 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $9,139 | $8,690 | $7,552 | $6,331 |
| Retained Earnings | -$10,835 | -$9,128 | -$7,728 | -$5,974 |
| AOCI | $21 | $12 | $0 | $0 |
| Other Equity | $2,125 | $1,862 | $1,641 | $1,550 |
| Total Equity | $450 | $1,436 | $1,465 | $1,906 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,598 | $2,164 | $2,095 | $2,567 |
| Net Debt | -$126 | $38 | -$6 | -$771 |